JavaScriptの設定を有効にしてからご利用いただきますようお願いいたします。(設定方法) 民営コングロマリット復星国際(00656)の傘下の製薬会社、上海復星医薬は、製品開発や商業化という点で、国内外企業とのビジネス展開に成功してきたが、短期的に ...
-
-
Recent Updates
- Global rare earth magnet industry impacted by shifts in North American supply management
- Shein’s Bumpy Road to Hong Kong’s IPO Success
- Shein Secures Approval for Hong Kong IPO After Failed Attempts in New York and London
- Shein Secures Approval for Hong Kong IPO After Failed Attempts in New York and London
- Shanghai ranks second among shipping centers
- Exciting Reveals for STACK Wigan’s Upcoming Food and Drink Market Unveiled
- Tencent Enters Talks to Acquire Manus After Meta’s Deal Falls Through
- Tencent Enters Talks to Acquire Manus After Meta’s Deal Falls Through
- Tencent Enters Talks to Acquire Manus After Meta’s Deal Falls Through
- Shein’s Path to Hong Kong IPO Approval Amid Global Strife
Blogroll